New hope for lung cancer patients with KRAS mutation: targeted drug MK-1084 under study

NCT ID NCT07252739

First seen Dec 16, 2025 · Last updated Jun 12, 2026 · Updated 26 times

Summary

This study tests a new targeted therapy, MK-1084, for people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. The goal is to see if the drug is safe and can shrink tumors. About 130 participants will receive the drug, and researchers will monitor side effects and how well the cancer responds.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • COMMUNAL NONPROFIT ENTERPRISE CLINICAL CENTER OF ONCOLOGY, HEMATOLOGY, TRANSPLANTOLOGY AND PALLIATI ( Site 0139)

    RECRUITING

    Cherkasy, Cherkasy Oblast, 18009, Ukraine

    Contact Phone: •••-•••-••••

  • Centro de Oncología de Precisión ( Site 0160)

    RECRUITING

    Santiago, Region M. de Santiago, 7560908, Chile

    Contact Phone: •••-•••-••••

  • Clermont Oncology Center ( Site 0041)

    RECRUITING

    Clermont, Florida, 34711, United States

    Contact Phone: •••-•••-••••

  • Communal Non-Commercial Enterprise "Prykarpatski Clinical On-Surgery department #2 ( Site 0132)

    RECRUITING

    Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76018, Ukraine

    Contact Phone: •••-•••-••••

  • Communal Noncommercial Enterprise "Podillia Regional Oncolog-Cardiothoracic department ( Site 0131)

    RECRUITING

    Vinnitsya, Vinnytsia Oblast, 21029, Ukraine

    Contact Phone: •••-•••-••••

  • Deventer Ziekenhuis ( Site 0272)

    RECRUITING

    Deventer, Overijssel, 7416 SE, Netherlands

    Contact Phone: •••-•••-••••

  • Fondazione IRCCS Istituto Nazionale Dei Tumori ( Site 0175)

    RECRUITING

    Milan, Lombardy, 20133, Italy

    Contact Phone: •••-•••-••••

  • HYKS Syöpätautien klinikka ( Site 0260)

    RECRUITING

    Helsinki, Uusimaa, 00290, Finland

    Contact Phone: •••-•••-••••

  • Hacettepe Universite Hastaneleri ( Site 0140)

    RECRUITING

    Ankara, 6230, Turkey (Türkiye)

    Contact Phone: •••-•••-••••

  • Hong Kong United Oncology Centre ( Site 0231)

    RECRUITING

    Kowloon, Hong Kong

    Contact Phone: •••-•••-••••

  • Hospital Universitario Virgen de la Macarena ( Site 0093)

    RECRUITING

    Seville, 41009, Spain

    Contact Phone: •••-•••-••••

  • Koç Üniversitesi Hastanesi ( Site 0142)

    RECRUITING

    Adana, 34010, Turkey (Türkiye)

    Contact Phone: •••-•••-••••

  • Kuopion Yliopistollinen Sairaala ( Site 0261)

    RECRUITING

    Kuopio, Northern Savonia, 70200, Finland

    Contact Phone: •••-•••-••••

  • LIMITED LIABILITY COMPANY "MEDICAL CENTER "DOBROBUT-CLINIC" ( Site 0138)

    RECRUITING

    Kyiv, 03151, Ukraine

    Contact Phone: •••-•••-••••

  • Leids Universitair Medisch Centrum ( Site 0273)

    RECRUITING

    Leiden, South Holland, 2333 ZA, Netherlands

    Contact Phone: •••-•••-••••

  • Limited Liability Company Ukrainian Center of Tomotherapy-Department of Chemotherapy ( Site 0467)

    RECRUITING

    Kropyvnytskyi, Kirovohrad Oblast, 25011, Ukraine

    Contact Phone: •••-•••-••••

  • Liv Hospital Ankara ( Site 0146)

    RECRUITING

    Ankara, 06680, Turkey (Türkiye)

    Contact Phone: •••-•••-••••

  • Lviv Territorial Medical Union Multidisciplinary Clinical Hospital ( Site 0133)

    RECRUITING

    Lviv, Lviv Oblast, 79059, Ukraine

    Contact Phone: •••-•••-••••

  • Medical Center "Mriya Med-Service"-Clinical Research Department ( Site 0465)

    RECRUITING

    Kryvyi Rih, Dnipropetrovsk Oblast, 50000, Ukraine

    Contact Phone: •••-•••-••••

  • Queen Mary Hospital ( Site 0230)

    RECRUITING

    Pokfulam, Hong Kong

    Contact Phone: •••-•••-••••

  • Sanford Cancer Center Oncology Clinic ( Site 0038)

    RECRUITING

    Sioux Falls, South Dakota, 57104, United States

    Contact Phone: •••-•••-••••

  • Sanford Health Roger Maris Cancer Center ( Site 0039)

    RECRUITING

    Fargo, North Dakota, 58102, United States

    Contact Phone: •••-•••-••••

  • Severance Hospital Yonsei University Health System ( Site 0080)

    RECRUITING

    Seoul, 03722, South Korea

    Contact Phone: •••-•••-••••

  • Turku University Hospital ( Site 0262)

    RECRUITING

    Turku, Southwest Finland, 20520, Finland

    Contact Phone: •••-•••-••••

  • Uzhhorod Municipal Multidisciplinary Clinical Hospital of Uzhhorod City Council ( Site 0137)

    RECRUITING

    Uzhhorod, Zakarpattia Oblast, 88000, Ukraine

    Contact Phone: •••-•••-••••

  • VISION PARTNER Medical Centre ( Site 0135)

    RECRUITING

    Kyiv, 03022, Ukraine

    Contact Phone: •••-•••-••••

  • Vaasan Keskussairaala ( Site 0263)

    RECRUITING

    Vaasa, Pohjanmaa, 65130, Finland

    Contact Phone: •••-•••-••••

  • West China Hospital, Sichuan University ( Site 0315)

    RECRUITING

    Chengdu, Sichuan, 610066, China

    Contact Phone: •••-•••-••••

Conditions

The condition(s) this trial relates to.

autosomal dominant Parkinson disease 4 neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.